3-12807380-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001162499.2(CAND2):c.287G>A(p.Arg96Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000509 in 1,551,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001162499.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAND2 | NM_001162499.2 | c.287G>A | p.Arg96Gln | missense_variant | Exon 3 of 15 | ENST00000456430.6 | NP_001155971.1 | |
CAND2 | XM_011533504.3 | c.215G>A | p.Arg72Gln | missense_variant | Exon 3 of 15 | XP_011531806.1 | ||
CAND2 | XM_011533503.3 | c.287G>A | p.Arg96Gln | missense_variant | Exon 3 of 14 | XP_011531805.1 | ||
CAND2 | NM_012298.3 | c.213-2679G>A | intron_variant | Intron 2 of 12 | NP_036430.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 156794Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 83060
GnomAD4 exome AF: 0.0000500 AC: 70AN: 1399436Hom.: 0 Cov.: 35 AF XY: 0.0000565 AC XY: 39AN XY: 690220
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152292Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.287G>A (p.R96Q) alteration is located in exon 3 (coding exon 3) of the CAND2 gene. This alteration results from a G to A substitution at nucleotide position 287, causing the arginine (R) at amino acid position 96 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at